Table 3.
Characteristics of patients requiring perioperative blood transfusion following scheduled glioma surgery
| Variables | Non-Transfusion (N=164) | Transfusion (N=157) | P value |
|---|---|---|---|
| Age(year) | 47.12 ± 10.36 | 56.96 ± 8.34 | 0.02 |
| Gender | 0.10 | ||
| Female (%) | 46.95% | 45.86% | |
| Male (%) | 53.05% | 54.14% | |
| Location | 0.15 | ||
| Cerebellum | 5.49% | 3.18% | |
| Diencephalon | 11.59% | 9.55% | |
| Telencephalon | 71.34% | 72.61% | |
| Ventricle | 11.59% | 14.65% | |
| WHO Grade | 0.54 | ||
| I-II | 73.78% | 73.25% | |
| III-IV | 26.22% | 26.75% | |
| Surgery | 0.37 | ||
| Gross total resection | 88.41% | 83.44% | |
| Near total resection | 11.59% | 16.56% | |
| Hemoglobin (g/L) | 132.4 ± 15.24 | 122.79 ± 12.03 | 0.21 |
| Prothrombin time (INR) | 0.91 ± 0.08 | 0.95 ± 0.07 | 0.47 |
| aPTT (s) | 24.47 ± 5.18 | 27.68 ± 4.34 | 0.28 |
| Platelet count ( 109/L) | 167.67 ± 49.40 | 165.41 ± 65.29 | 0.79 |
| RBC(1012/L) | 4.6 ± 0.70 | 4.41 ± 0.85 | 0.06 |
| Hematocrit (%) | 37.45 ± 3.31 | 34.56 ± 4.23 | 0.10 |
| WBC count ( 109/L) | 13.24 ± 5.36 | 9.56 ± 5.69 | 0.05 |
| Postoperative hospital stay (day) | 11.19 ± 4.56 | 13.04 ± 6.36 | 0.21 |